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Biochemistry
Insulin stimulates the dephosphorylation and activation of
acetyl-CoA carboxylase
LEE A. WITTERS*, THOMAS D. WATTS, DIANA L. DANIELS, AND JOSEPH L. EVANS
Endocrine-Metabolism Division, Departments of Medicine and Biochemistry, Dartmouth Medical School, Hanover, NH 03756
Communicated by P. Roy Vagelos, April 11, 1988
ABSTRACT The mechanism underlying the ability of
insulin to acutely activate acetyl-CoA carboxylase [acetyl-CoA:
carbon-dioxide ligase (ADP-forming), EC 6.4.1.2; AcCoA-
Case] has been examined in Fao Reuber hepatoma cells. Insulin
promotes the rapid activation of AcCoACase, as measured in
cell lysates, and this stimulation persists to the same degree
after isolation of AcCoACase by avidin-Sepharose chromatog-
raphy. The insulin-stimulated enzyme, as compared with
control enzyme, exhibits an increase in both citrate-indepen-
dent and -dependent activity and a decrease in the Ka for
citrate. Direct examination of the phosphorylation state of
isolated 32P-labeled AcCoACase after insulin exposure reveals
a marked decrease in total enzyme phosphorylation coincident
with activation. The dephosphorylation due to insulin appears
to be restricted to the phosphorylation sites previously shown
to regulate AcCoACase activity. All of these effects of insulin
are mimicked by a low molecular weight autocrine factor,
tentatively identified as an oligosaccharide, present in condi-
tioned medium of hepatoma cells. These data suggest that
insulin may activate AcCoACase by inhibiting the activity of
protein kinase(s) or stimulating the activity of protein phos-
phatase(s) that control the phosphorylation state of the enzyme.
The activity of acetyl-CoA-carboxylase [acetyl-CoA:carbon-
dioxide ligase (ADP-forming), EC 6.4.1.2; AcCoACase], a
rate-limiting enzyme for fatty acid biosynthesis, may be
rapidly modulated by several hormones. Epinephrine in rat
adipose tissue and glucagon in rat liver and adipose tissue
promote the inactivation of AcCoACase (1-3). This inacti-
vation persists after purification of the enzyme to homoge-
neity and can be accounted for by agonist-stimulated increase
in AcCoACase phosphorylation (1, 3). This hormone-
mediated inactivation can be entirely mimicked by phosphor-
ylation of the enzyme in vitro by the cAMP-dependent
protein kinase and some other kinases active on AcCoACase
(1, 3, 4).
The mechanism(s) by which insulin rapidly activates Ac-
CoACase has proven to be elusive. Insulin in rat adipose
tissue and adipocytes stimulates the activity of AcCoACase
as measured in crude cellular extracts (1, 5-7). However, this
stimulation has not persisted when the enzyme was isolated
by avidin-Sepharose chromatography (1, 7, 8). Contrary to
the expected dephosphorylation of AcCoACase in response
to insulin, the only observed effect of insulin on the phos-
phorylation state of AcCoACase has been an increase in
phosphorylation at a site distinct from that phosphorylated in
response to epinephrine or glucagon (1, 5, 7, 8). It has been
alternatively suggested that the insulin stimulation of Ac-
CoACase is not due to a change in the phosphorylation state
but rather to an unidentified allosteric regulator (7). In
addition, insulin appears to promote the polymerization of
the enzyme in rat adipose tissue (9, 10).
The relationship between insulin activation ofAcCoACase
and changes in its phosphorylation state has been clarified in
the present study. Our results indicate that both insulin and
an insulinomimetic oligosaccharide promote the dephos-
phorylation of AcCoACase coincident with its activation in
Fao Reuber ("Fao") hepatoma cells.
MATERIALS AND METHODS
32Pi (carrier free) and NaH14CO3 were purchased from ICN.
125I-labeled goat anti-mouse Ig was purchased from New
England Nuclear. Cell culture media were obtained from
GIBCO, and calf serum was from HyClone (Logan, UT).
Insulin was a gift of Ronald Chance (Eli Lilly). All other
chemicals were obtained from Sigma. Nitrocellulose was
obtained from Schleicher & Schuell.
Cell Culture. Fao hepatoma cells were a kind gift of C.
Ronald Kahn (Harvard Medical School). Fao cells were
grown in RPMI 1640 medium supplemented with 2.5% fetal
calf serum, 2.5% calf serum, and penicillin/streptomycin at
37°C in a humidified atmosphere of 5% C02/95% air. All
experiments were performed under serum-free conditions, as
detailed below. H-35 hepatoma cells (a gift of Michael
Czech), used for the production of the autocrine factor, were
grown in Dulbecco's minimal essential medium supple-
mented with identical medium additions.
Experimental Design and Cell Labeling with 32p;. Fao cells
were seeded into P-100 plates (Coming) at 1 x 106 cells per
plate and grown to 60-70% confluence over 3-4 days. The
cells were then washed three times with 4 ml of ice-cold
phosphate-buffered saline and then incubated for 1 hr in
serum-free medium. This cycle of washing and serum-free
incubation was then repeated two more times. The medium
was again changed, and hormone additions were made after
an additional 15 min. After 30 min of hormone exposure, the
cells were washed twice with ice-cold phosphate-buffered
saline and then lysed with a digitonin-containing buffer. Cell
lysates were prepared by the addition of 400 ,u1 of a buffer
(4°C) containing 50 mM Tris chloride (pH 7.5), 1 mM EDTA,
0.1 M NaF, 10 mM 2-mercaptoethanol, 0.25 M sucrose, 0.4
mg of digitonin per ml, and seven protease inhibitors, as in
ref. 11. The plates were rocked manually for 2 min; the lysate
was removed and added directly to 0.1 vol of the same buffer
without digitonin and containing 60 mg of fatty acid-free
bovine serum albumin per ml on ice. This method of lysis was
shown to remove quantitatively all of the AcCoACase, as
judged by immunoblotting of lysates and residual cell pellets
(data not shown). In each of the experiments reported here,
lysates from six P-100 plates for each experimental condition
were pooled in the same tube. An aliquot of this mixture was
then removed for determination ofAcCoACase activity. The
remainder was then dialysed overnight against the avidin-
Sepharose chromatography buffer (see below) used for iso-
lation of AcCoACase.
Abbreviation: AcCoACase, acetyl-CoA-carboxylase.
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32P-labeling was done under identical conditions except
that phosphate-free serum-free medium was -used in the
preliminary washing cycles, and the intermittent washings
were done with Krebs-Ringer buffer containing 10 mM
sodium Hepes (pH 7.4). Prior to hormone addition, the cells
were additionally equilibrated with carrier-free 32p; (0.2
mCi/ml; 1 Ci = 37 GBq) for 2 hr. After hormone stimulation,
lysates were prepared as with the unlabeled cells. Preliminary
experiments established that these changes in the cell incu-
bation protocol did not affect the hormonal stimulations
previously observed in unlabeled cells.
AcCoACase Isolation. After dialysis, the extracts were
applied to 1.0-ml monomeric avidin-Sepharose columns (11)
equilibrated in 50 mM Tris chloride, pH 7.5/0.5 M NaCl/0.1
M NaF/2 mM EDTA/10 mM 2-mercaptoethanol/0.02%
NaN3/10% (vol/vol) glycerol. The columns were then
washed with >50 column vol of buffer; AcCoACase was then
eluted in 2.5 ml of the same buffer containing 2 mM biotin
directly into a plastic tube containing 0.25 ml of the same
buffer containing 10 mg of bovine serum albumin per ml. The
latter was added to diminish adsorption of the small amounts
of eluted protein to the tube. These eluates and aliquots of the
original lysates were then dialyzed against the original lysis
buffer (without digitonin) overnight to diminish the high salt
concentration, which interferes with the assay of enzyme
activity. After dialysis, the fractions were assayed for Ac-
CoACase activity, and samples of the eluates were prepared
either for immunoblotting (unlabeled extracts) or for
NaDodSO4 gel electrophoresis and radioautography (labeled
extracts).
AcCoACase Activity and Immunoblotting. The activity of
AcCoACase was determined by H14CO- fixation in the
presence of various concentrations of citrate (0-10 mM) (12)
modified by the substitution of acetate salts of Tris and Mg2 +
for the chloride ones. AcCoACase mass in the avidin-
Sepharose eluates of unlabeled extracts was determined by
quantitative immunoblotting with an AcCoACase monoclo-
nal antibody after NaDodSO4 gel electrophoresis and transfer
to nitrocellulose as in ref. 13. As shown in the autoradiogram
in Fig. 1 Upper, a single band of Mr 240,000 in purified rat
liver AcCoACase is recognized by this antibody.
Miscellaneous Methods. AcCoACase was isolated from the
livers of Sprague-Dawley rats who had been fasted for 48 hr
and then refed for 48 hr with a low-fat high-carbohydrate diet
as described (11). Casein kinase II was purified from rat liver
as in ref. 14. HPLC mapping of 32P-labeled AcCoACase
tryptic peptides was performed as described (1). The insulin-
omimetic oligosaccharide was partially purified from H-35
conditioned medium through the P2 gel filtration step as
described (15). NaDodSO4 polyacrylamide gels were per-
formed by the method of Laemmli (16).
RESULTS
AcCoACase Activation in Fao Cells. As measured in cell
lysates, both insulin and the insulinomimetic oligosaccharide
factor increased the activity ofAcCoACase; the largest effect
was evident in the citrate-independent activity, although
there was also an increase in citrate-dependent activity
(Table 1). The degree of stimulation ofAcCoACase by insulin
is typical of that observed in extracts of other cells (1, 2, 5-
7, 12). After purification ofAcCoACase by the highly specific
monomeric avidin-Sepharose method, the insulin- and factor-
stimulated increases persisted to the same extent. Because of
the low ahiounts ofAcCoACase isolated in these experiments
(1-2.5 ,ug from each pool of six P-100 plates) and their dilution
in an albumin-containing buffer, we cannot claim that this is
a homogeneous preparation based on protein assay or stain-
ing of NaDodSO4 gels, although homogenous preparations
are obtained from rat liver by the same isolation technique
Proc. Natl. Acad. Sci. USA 85 (1988)
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FIG. 1. Immunoblot analysis of purified AcCoACase derived
from rat liver and Fao hepatoma cells. AcCoACase content in
avidin-Sepharose isolates from Fao cells was determined by immu-
noblotting with AcCoACase monoclonal antibody as detailed.
(Upper) Representative immunoblot derived from NaDodSO4 gel
electrophoresis (7.2% gels) and electrotransfer to nitrocellulose of
various amounts of purified rat liver AcCoACase. The following
amounts of AcCoACase were loaded in respective lanes: 1, 200 ng;
2, 160 ng; 3, 100 ng; 4, 80 ng; 5, 40 ng; 6, 20 ng; and 7, 10 ng. These
bands were then excised, and radioactivity was determined to
construct a standard cover. (Lower) Immunoblot derived from the
analysis of avidin-Sepharose isolates from control (lanes C), insulin-
stimulated (lanes I), and factor-stimulated (lanes F) Fao cells in four
experiments (1-4); 16 ,ul of each eluate fraction was loaded on each
lane of the NaDodSO4 gel. The content of AcCoACase in each was
then determined by excision of the labeled band, assay of "25I, and
comparison to the standard curve.
(11). However, the immunoblot technique does allow a
precise estimate of AcCoACase content in the isolates. As
shown in Fig. 1 Lower, a single band of Mr 240,000 that
comigrates with rat liver AcCoACase was detected in the
avidin-Sepharose eluates, and there were no significant
differences in the recovery of this protein between control
and agonist-stimulated isolations in four experiments (see
also Table 1). This immunoblot technique allowed us to
express the data as units of enzyme activity per mg of
AcCoACase protein (Table 1); these estimates of specific
activity were in good agreement with those of AcCoACase
isolated from whole rat liver under a variety of nutritional
conditions (11, 17). In addition, there was no significant
difference in the percentage of enzyme activity recovered
upon purification from control and stimulated lysates.
Comparison of the kinetic properties of AcCoACase iso-
lated from control and stimulated cells indicates three
changes that occurred with activation (Table 1 and Fig. 2).
The largest effect of insulin and the factor was on citrate-
independent activity (2- to 3-fold). There was also a 50%
decrease in the Ka for citrate and a 50% increase in maximal
activity measured at saturating citrate concentrations.
Changes in AcCoACase Phosphorylation. The persistence
of AcCoACase activation after dialysis against high-salt
buffers and, most importantly, after isolation by avidin-
Sepharose chromatography suggests strongly that the insu-
lin- and factor-stimulated change in AcCoACase activity is
due to a covalent modification. While proteolysis can lead to
AcCoACase activation (18), no evidence of altered molecular
size was evident on the immunoblot (Fig. 1 Lower). There-
fore, we next examined the effects of these stimulators on the
phosphorylation state of AcCoACase as isolated from 32P-
labeled cells. A single [32P]phosphoprotein of Mr 240,000,
which comigrated with AcCoACase isolated from rat liver,
was detected in the avidin-Sepharose eluates (Fig. 3 Left).
The apparent 32p content of AcCoACase was markedly
diminished in isolates from insulin- and factor-stimulated
Proc. Natl. Acad. Sci. USA 85 (1988) 5475
Table 1. AcCoACase activity in Fao cell lysates and avidin-Sepharose isolates
Insulin- Factor-
Control stimulated stimulated
Cell lysates V10, mU/mg of protein 7.76 ± 0.56 10.39 + 1.13 11.47 ± 1.33
VO, mU/mg of protein 0.98 ± 0.11 2.01 ± 0.21 2.23 ± 0.21
AcCoACase isolates V10, U/mg of ACC 1.88 ± 0.18 2.67 ± 0.06 2.95 ± 0.28
VO, U/mg of ACC 0.24 ± 0.04 0.63 ± 0.15 0.88 + 0.17
Ka citrate, mM 1.13 ± 0.28 0.43 ± 0.06 0.51 ± 0.07
AcCoACase protein, % control 100 109 ± 28 119 ± 32
AcCoACase activity recovery 25.4 ± 7.7 25.6 ± 5.0 25.5 ± 10.4
AcCoACase activity was determined in lysates of Fao cells after stimulation with insulin (100 nM)
or the autocrine factor for 30 min in six experiments with separate platings of cells as detailed. In these
experiments, the lysate was not added to the excess concentration of bovine serum albumin to permit
precise estimation of its protein content. These lysate data are expressed as the means (± SD) of
AcCoACase activity (milliunits per mg of lysate protein) measured in the absence (V0) or presence (V1O)
of a saturating (10 mM) citrate concentration. In a separate series of four experiments, AcCoACase
activity was measured after isolation of the enzyme from lysates by avidin-Sepharose chromatography.
AcCoACase content in these isolates was determined by quantitative immunoblotting by excision and
counting of the 251I-labeled band on blots with comparison to a standard curve constructed with isolated
AcCoACase. The results are expressed as units of AcCoACase activity per mg of AcCoACase protein
(means ± SD). The Ka for citrate (± SEM) was determined in these same isolates by enzyme assay at
variable citrate concentrations; these data were analyzed by linear double reciprocal plots of 1/V -
V0 versus 1/[citrate], and the Ka was determined by linear regression analysis. The recovery of
AcCoACase protein through isolation is depicted as percent control recovery (± SD), as judged by
immunoblotting. The total recovery varied between experiments with separate cell platings between 1
and 2.5 ,g ofAcCoACase protein per total volume of the eluate but did not differ significantly between
control, insulin-, or factor-stimulated isolates within each experiment (see also Fig. 1 Lower).
AcCoACase activity recovery was calculated based on assays of the lysates and the final eluates, as
measured at a maximally stimulating citrate concentration; these data are expressed as % total lysate
activity (± SD) recovered in the avidin-Sepharose eluates. The differences in AcCoACase activity
parameters between control and agonist-stimulated are all significant at P < 0.005, as determined by
Student's t test.
cells. In this same experiment, AcCoACase activity was
enhanced in the insulin and factor-stimulated isolates coin-
cident with this decrease in total 32p content (Fig. 3 Right).
The 32P-labeling protocol did not alter the stimulations of
AcCoACase activity observed in unlabeled cells (compare
Table 1 and Fig. 3). We were unable to measure the mass of
AcCoACase in the 32P-labeling experiments because of
interference of 32p with the 1251-labeled immunoblot. The
results presented in Table 1 derived from unlabeled cells
argue strongly that the difference in 32P radioactivity seen in
the cell-labeling experiments was not due to a difference in
AcCoACase mass in the isolates. Because of our inability to
quantitate AcCoACase mass in the 32P-labeled isolates, we
also have presented the results in these experiments both as
32p content per total eluate and as 32p content per microunit
4-)3
2 4 6 8 10
[Citrote], mM
FIG. 2. AcCoACase activity as a function ofcitrate concentration
in control, insulin-stimulated, and factor-stimulated AcCoACase
isolates. Shown is a representative experiment in which AcCoACase
activity was determined at variable concentrations of citrate in the
assay in avidin-Sepharose isolates from control (A), insulin-
stimulated (o), and factor-stimulated (o) cells. The AcCoACase
activity is expressed as units per mg ofAcCoACase protein; the latter
was determined by quantitative immunoblotting, as in Fig. 1.
of AcCoACase activity in the absence and presence of
citrate, the latter ratio being independent of enzyme mass
(Table 2). Both total 32P content in the eluate and this ratio
were decreased in insulin- and factor-stimulated isolates, the
ACC *la. .081
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FIG. 3. Analysis of 32P-labeled AcCoACase by radioautography
and enzyme assay. (Left) Representative autoradiogram of 32p_
labeled avidin-Sepharose isolates separated on a NaDodSO4/7.2%
gel. Isolates (32 1.A) from control (lane C), insulin-stimulated (lane I),
and factor-stimulated (lane F) preparations were loaded on the gel in
this experiment. The 32P-labeled band comigrates with the Coomas-
sie blue-stained Mr 240,000 subunit of rat liver AcCoACase (indi-
cated to left). (Right) AcCoACase activity measured in the presence
and absence of a saturating citrate concentration (10 mM) of these
three isolates (o, control; c, insulin-stimulated preparation; and C,
factor-stimulated preparation) in the same experiment. These results
are expressed as milliunit per ml of isolate, since AcCoACase
content could not be determined in these experiments by immuno-
blotting (see text).
Cilrate Citrole
0 mM 10 mM
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Table 2. 32p content and AcCoACase activity of isolates from 32P-labeled cells
Insulin- Factor-
Exp. Control stimulated stimulated
32p, cpm per eluate 1 6150 (100) 3860 (63) 3440 (56)
2 3864 (100) 2026 (52) 1936 (50)
32p, cpm per microunit of AcCoACase
Citrate (0 mM) 1 228 (100) 81 (36) 46 (20)
2 77 (100) 34 (44) 30 (39)
(10 mM) 1 9.2 (100) 5.6 (61) 4.2 (46)
2 6.6 (100) 3.8 (57) 2.1 (32)
Shown are two representative experiments derived from isolation of AcCoACase from 32P-labeled
cells after exposure to the control vehicle, insulin (100 nM), and factor for 30 min as detailed. In a third
experiment, the same changes in 32p content were observed, but activity was not determined. 32p
content is expressed as cpm per total volume of the dialyzed eluate; all radioactivity was precipitable
with 25% trichloroacetic acid, and a single radiolabeled band was detected on NaDodSO4 gel
electrophoresis and radioautography (see Fig. 3). Because AcCoACase content could not be
determined in these experiments (see text), the data have been normalized to the measurement of
AcCoACase activity at 0 and 10 mM citrate in these same isolates and are presented as cpm of 32p per
microunit of AcCoACase activity. In parentheses is shown the percentage of each parameter relative
to the control (= 100).
latter at each concentration of citrate. These data indicate
that, per unit of enzyme activity, the AcCoACase isolated
from insulin- and factor-stimulated cells is relatively dephos-
phorylated.
Preliminary mapping of tryptic phosphopeptides by re-
verse-phase HPLC from 32P-labeled cells revealed a pattern
of site-directed phosphorylation similar to that previously
observed in both rat adipocytes and hepatocytes and after in
vitro phosphorylatioh of AcCoACase with various protein
kinases (not shown) (1, 3, 4). The agonist-stimulated dephos-
phorylation appeared to occur on a peptide that could be
labeled in vitro on incubation of isolated rat liver AcCoACase
with the cAMP-dependent protein kinase and an endogenous
5'-AMP-stimulated kinase present in highly purified prepa-
rations ofAcCoACase. t No change in the phosphorylation of
a second peptide that can be labeled in vitro with casein
kinase II was seen either in response to insulin or the
oligosaccharide. Thus, the agonist-mediated dephosphoryla-
tion ofAcCoACase appeared to occur in the phosphorylation
site(s) that is phosphorylated in the intact cell in response to
agonists, such as glucagon and epinephrine, which inactivate
the enzyme in intact cells and in vitro upon incubation with
AcCoACase-inactivating protein kinases.
DISCUSSION
The results of the present study indicate that enzyme de-
phosphorylation is the mechanism by which insulin and an
insulinomimetic autocrine factor produced by Reuber hepa-
toma cells acutely increase the activity ofAcCoACase in Fao
cells. Persistence of the agonist-induced activity change with
purification of the enzyme coupled with changes in 32P
content argue persuasively for this underlying covalent
change being responsible for the alteration in catalytic
activity.
Several laboratories, including our own, have previously
described an increase in AcCoACase phosphorylation in
response to insulin in rat adipocytes and hepatocytes (1, 5, 7,
8). However, the insulin-stimulated change in AcCoACase
activity detectable in crude cellular extracts has not persisted
heretofore to the same extent on purification of the enzyme,
tHighly purified rat liver AcCoACase preparations contain an
inactivating protein kinase (11). Recent experiments have deter-
mined that the activity of this kinase towards AcCoACase is
markedly stimulated (6- to 10-fold) by 5'-AMP; half-maximal stim-
ulation occurs at 20 ,IM 5'-AMP, with maximal stimulation at 200
,uM (A. Bianchi and L. A. W., unpublished observations). This
kinase is likely identical to that described by others (19).
making linkage between this phosphorylation change and
changes in catalytic activity uncertain. Our current experi-
ments indicate that the dephosphorylation of AcCoACase is
largely confined to one or more phosphorylation sites that are
phosphorylated in vitro by two protein kinases (the cAMP-
dependent protein kinase and an endogenous 5'-AMP-
stimulated protein kinase) accompanied by enzyme inactiva-
tion. Therefore, dephosphorylation of these sites would be
expected to increase AcCoACase activity. This same phos-
phorylation site(s) also appears to be phosphorylated in
response to glucagon and epinephrine in rat cells coincident
with enzyme inactivation (1, 3)
Dephosphorylation of AcCoACase in vitro by various
protein phosphatases has long been recognized to lead to
enzyme activation (4, 7, 11, 17, 20-23). This mechanism also
has been demonstrated directly to occur in vivo in rat
mammary tissue with alterations in nutrition (23) and has
been postulated to occur in vivo in response to an acute
glucose challenge (17, 24). The alterations in citrate-
independent activity, maximal enzyme velocity (at maximal
stimulating citrate concentrations), and Ka for citrate ob-
served in the present study in response to insulin and the
factor are entirely consistent with the demonstration of
enzyme dephosphorylation, based on analogy to the protein
phosphatase experiments. Each of these kinetic parameters
has been shown to be influenced in the same way by in vitro
dephosphorylation of AcCoACase (7, 17, 20-24).
The inability to maintain the insulin-stimulated increase in
AcCoACase activity through enzyme purification has led
others to suggest that insulin regulation occurs through an
allosteric mechanism because of some unidentified allosteric
regulator (7). This observation was based on the loss of
insulin-stimulated AcCoACase activity after desalting of
crude cell extracts in the presence ofhigh salt concentrations.
In the present study, we have been able to maintain the
insulin-stimulated increase in activity after dialysis against a
high-salt buffer, extensive high-salt washing after enzyme
immobilization of avidin-Sepharose, and subsequent dialysis
of biotin eluates of these columns. These observations argue
strongly against such an allosteric mechanism.
Our previous inability and that of others (1, 5, 7, 8) to
demonstrate insulin-stimulated dephosphorylation of Ac-
CoACase coincident with enzyme activation is not explain-
able based on the present results. Some studies have been
carried out in collagenase-isolated rat cells rather than in
cultured cells. It is possible that collagenase isolation influ-
ences the experimental results. Alternatively, the hepatoma
cells in culture might display unique regulatory properties.
The technique of digitonin lysis used in this study allows
5476 Biochemistry: Witters et al.
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rapid release ofthe cytosolic contents into a buffer containing
both phosphatase and protease inhibitors; this rapid
'quenching" may be necessary.
The present results suggest that attention should be drawn
to insulin's ability to inhibit a cellular protein kinase that
leads to AcCoACase inactivation or to activate a protein
phosphatase that leads to site-specific dephosphorylation.
Such kinases include the cAMP-dependent protein kinase
and other cAMP-independent kinases (1, 4, 10, 19, 24, 25).
While the kinases have some site specificity, the protein
phosphatases active on AcCoACase in rat liver apparently do
not discriminate between phosphorylation sites labeled by
the cAMP-dependent protein kinase, casein kinase I, and
casein kinase II (26). This nonselectivity makes it difficult to
explain a discrete site-specific dephosphorylation in response
to insulin as being due to activation of one of these phos-
phatases. These observations make it reasonable to speculate
that the effect of insulin and the autocrine factor could be due
to inhibition of one or more of the protein kinases active on
AcCoACase.
We also have not observed an increase in phosphorylation
in response to insulin in the AcCoACase peptide observed in
previous experiments. This phosphorylation may be medi-
ated by casein kinase 11 (1, 8). Phosphorylation of AcCoA-
Case in vitro by this kinase has no effect on its kinetic
properties (4, 14). It is possible that this phosphorylation
occurs in adipocytes and in hepatocytes from fasted/refed
rats because of the relative abundance of AcCoACase in
these cells, as opposed to the cultured hepatoma cells.
Alternatively, it is possible that the ability of insulin to
dephosphorylate and activate AcCoACase is the result of a
concerted phosphorylation/dephosphorylation occurring at
separate phosphorylation sites. Sommercorn and co-workers
have shown that insulin can cause a rapid activation of casein
kinase II in 3T3-L1 adipocytes and Reuber hepatoma cells
(27). In addition, this laboratory has reported that when
AcCoACase is phosphorylated in vitro by this kinase, the rate
ofdephosphorylation ofa separate site phosphorylated by the
cAMP-dependent protein kinase is accelerated (28). We
cannot exclude that such a concerted mechanism has not
occurred in our cell lines, since the phosphorylation mea-
surements were only done at a single time point (30 min).
The effects of insulin in these experiments were entirely
mimicked by the autocrine factor, which has been partially
purified from the conditioned medium of Reuber hepatoma
cells (15). This factor may be identical to a polar oligosac-
charide isolated after digestion of a glycophospholipid with a
phosphatidylinositol-specific phospholipase C and after ex-
posure ofBC3H1 myocytes to insulin; these oligosaccharides
have several other insulinomimetic actions in both whole
cells and in vitro (29-33). While we have no evidence at
present that this factor is generated in hepatoma cells in
response to insulin, its ability to mimic the action of insulin
to stimulate and dephosphorylate AcCoACase has provided
a valuable probe that could be useful in identifying the locus
of insulin regulation.
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